GlassScriptPhysician profile
April D Claxton
NPI 1821731084
$6,894.33
in general payments reported to CMS, 2019-2025
43 companies · $2,205 in 2025
The $2,205 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $198 · 2023: $2,578 · 2024: $1,914 · 2025: $2,205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,873 · Travel and Lodging: $757 · Education: $67.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,872.99 |
| Travel and Lodging | $756.75 |
| Education | $67.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $2,017.32 | 2023-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $766.83 | 2023-2025 | |
| Ucb, INC. | $640.57 | 2023-2025 | Nayzilam, Fintepla, Briviact |
| Teva Pharmaceuticals USA, INC. | $503.94 | 2022-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Neurocrine Biosciences, INC. | $489.24 | 2022-2025 | Ingrezza, Ongentys |
| Sk Life Science, INC. | $360.40 | 2022-2025 | |
| Lundbeck LLC | $193.01 | 2023-2025 | Vyepti, Rexulti |
| Eisai INC. | $169.65 | 2022-2025 | |
| Corium, LLC | $164.77 | 2022-2023 | Adlarity, Adlarity |
| Jazz Pharmaceuticals INC. | $154.11 | 2023-2025 | |
| Harmony Biosciences LLC | $120.66 | 2023-2025 | Wakix |
| Inspire Medical Systems, INC. | $99.49 | 2023-2025 | Inspire |
| Ge Healthcare | $92.20 | 2023-2025 | |
| Pfizer INC. | $91.62 | 2024-2025 | |
| Merz Pharmaceuticals, LLC | $84.82 | 2025 | Xeomin, Inbrija |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Claxton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.